α1-Antitrypsin is an abundant plasma inhibitor of neutrophil elastase,expressed at high levels by hepatocytes, and one of the causative agents of a class of conformational diseases termed serpinopathies. In its active state, α1-antitrypsin is in a kinetically stable, but thermodynamically unstable, configuration, rendering it susceptible to inappropriate conformationalchange. In individuals homozygous for the Z (E342K) mutation, α1-antitrypsin accumulates in the liver as dense intracellular deposits, leading to a reduced level in circulation. These deposits are the consequence of an ‘ordered aggregation’ that yields linear, unbranched protein chains, termed polymers, that are both extremely stable and functionally inactive. The circulat...
The common severe Z mutation (E342K) of α1-antitrypsin forms intracellular polymers that are associa...
Protease inhibitors of the serpin family are characterised by a metastable native fold which is nece...
α1-Antitrypsin is primarily synthesised in the liver, circulates to the lung and protects pulmonary ...
The serpinopathies are among a diverse set of conformational diseases that involve the aberrant self...
The serpinopathies are among a diverse set of conformational diseases that involve the aberrant self...
α1-Antitrypsin is primarily synthesised in the liver, circulates to the lung and protects pulmonary ...
α1-Antitrypsin is primarily synthesised in the liver, circulates to the lung and protects pulmonary ...
The formation of ordered Z (Glu342Lys) α1 -antitrypsin polymers in hepatocytes is central to liver d...
Abstractα1-Antitrypsin is primarily synthesised in the liver, circulates to the lung and protects pu...
The serpinopathies result from the ordered polymerization of mutants of members of the serine protei...
The serpinopathies result from the ordered polymerization of mutants of members of the serine protei...
Alpha(1)-antitrypsin is the most abundant circulating protease inhibitor. The severe Z deficiency al...
α1-Proteinase inhibitor (antitrypsin) is a canonical example of the serpin family member that binds ...
Alpha(1)-antitrypsin is the most abundant circulating protease inhibitor. The severe Z deficiency al...
<div><p>α<sub>1</sub>-Proteinase inhibitor (antitrypsin) is a canonical example of the serpin family...
The common severe Z mutation (E342K) of α1-antitrypsin forms intracellular polymers that are associa...
Protease inhibitors of the serpin family are characterised by a metastable native fold which is nece...
α1-Antitrypsin is primarily synthesised in the liver, circulates to the lung and protects pulmonary ...
The serpinopathies are among a diverse set of conformational diseases that involve the aberrant self...
The serpinopathies are among a diverse set of conformational diseases that involve the aberrant self...
α1-Antitrypsin is primarily synthesised in the liver, circulates to the lung and protects pulmonary ...
α1-Antitrypsin is primarily synthesised in the liver, circulates to the lung and protects pulmonary ...
The formation of ordered Z (Glu342Lys) α1 -antitrypsin polymers in hepatocytes is central to liver d...
Abstractα1-Antitrypsin is primarily synthesised in the liver, circulates to the lung and protects pu...
The serpinopathies result from the ordered polymerization of mutants of members of the serine protei...
The serpinopathies result from the ordered polymerization of mutants of members of the serine protei...
Alpha(1)-antitrypsin is the most abundant circulating protease inhibitor. The severe Z deficiency al...
α1-Proteinase inhibitor (antitrypsin) is a canonical example of the serpin family member that binds ...
Alpha(1)-antitrypsin is the most abundant circulating protease inhibitor. The severe Z deficiency al...
<div><p>α<sub>1</sub>-Proteinase inhibitor (antitrypsin) is a canonical example of the serpin family...
The common severe Z mutation (E342K) of α1-antitrypsin forms intracellular polymers that are associa...
Protease inhibitors of the serpin family are characterised by a metastable native fold which is nece...
α1-Antitrypsin is primarily synthesised in the liver, circulates to the lung and protects pulmonary ...